Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

CureVac says preliminary trials show COVID-19 vaccine effective against variants

CureVac chief Franz-Werner Haas said on Thursday that preliminary trials on animals of the company's COVID-19 vaccine candidate show it is effective against the UK and South African variants.

Haas told EU lawmakers that the results of the preliminary trials on the vaccine's effects on variants would be published soon.

He also said that the company expected its vaccine to be approved in the European Union by June.

(Reporting by Francesco Guarascio @fraguarascio; Editing by Susan Fenton)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.